Spine Wave, Inc.

NEW YORK, Aug. 9, 2023 /PRNewswire/ -- The spinal implants and surgical devices market is estimated to grow at a CAGR of 5.3% between 2022 and 2027. The market size is forecasted to increase by USD 3,394.36 million, according to Technavio. - Request a sample report Spinal Implants and Surgical Devices Market Insights - Continue Reading Technavio has announced its latest market research report titled Global Spinal Implants and Surgical Devices Market Companies: 15+, Including Abbott Laboratories, Alphatec Holdings Inc., B. Braun Melsungen AG, Bioventus LLC, Boston Scientific Corp., Exactech Inc., Globus Medical Inc., Implanet SA, Integra Lifesciences Holdings Corp., Johnson and Johnson Services Inc., Kuros Biosciences AG, Medtronic Plc, Nuvasive Inc., Orthofix Medical Inc., RTI Surgical Inc., Spine Wave Inc., Spineart SA, Stryker Corp., ulrich GmbH and Co. KG, and Xtant Medical Inc., among others Coverage: Parent market analysis; key drivers, major trends, and challenges; customer and company landscape; company product insights and recent developments; key companies; and market positioning of companies Segments: type (open surgeries and minimally invasive surgeries), end-user (hospitals, ambulatory surgical centers, and specialty clinics), and geography (North America, Europe, Asia, and the Rest of World (ROW)) To understand more about the spinal implants and surgical devices market, request a sample report Spinal Implants and Surgical Devices Market - Company Insights The growing competition in the market is compelling companies to adopt various growth strategies such as promotional activities and spending on advertisements to improve the visibility of their services. Technavio report analyzes the market's competitive landscape and offers information on several market companies including - Abbott Laboratories, Alphatec Holdings Inc., B. Braun Melsungen AG, Bioventus LLC, Boston Scientific Corp., Exactech Inc., Globus Medical Inc., Implanet SA, Integra Lifesciences Holdings Corp., Johnson and Johnson Services Inc., Kuros Biosciences AG, Medtronic Plc, Nuvasive Inc., Orthofix Medical Inc., RTI Surgical Inc., Spine Wave Inc., Spineart SA, Stryker Corp., ulrich GmbH and Co. KG, and Xtant Medical Inc. Spinal Implants and Surgical Devices Market – Market Dynamics Key Drivers The increasing prevalence of spinal disorders is a key factor driving market growth. Common spinal diseases such as degenerative disc disease, spinal stenosis, and disc herniation are becoming increasingly prevalent due to an aging population, resulting in increased demand for spinal surgery and implants. Degenerative diseases such as arthrosis and degenerative disc disease are particularly common with aging, causing spinal pain and functional limitations. This increases the need for spinal implants and surgical instruments. Additionally, a sedentary lifestyle negatively impacts spinal health, resulting in poor posture, weak back muscles, increased pressure on the spine, and symptoms such as lower back pain, disc herniation, and spinal stenosis. This can also cause medical societies and device manufacturers to actively raise awareness of these spinal disorders through educational programs and conferences. Hence, weak, or missing MRO processes are expected to restrict market growth during the forecast period. Major Trends Technological advancements is a major trend in the market. Minimally invasive surgical techniques, robotic surgery, 3D printing of implants, advanced imaging techniques, and the development of biocompatible materials for implants are some of the recent technological advances in the market. In addition, these innovations aim to improve surgical outcomes, reduce patient recovery time, and improve the overall quality of spine surgery. Titanium alloys and polyetheretherketone (PEEK) are among the advanced materials for implants, offering good mechanical properties and compatibility with the human body. Additionally, the minimally invasive technique requires smaller incisions, reducing tissue damage and shortening patient recovery time. Ongoing research at various universities is exploring the potential of his 3D printing in spine surgery. Hence, technological advancements are expected to drive market growth during the forecast period. Significant Challenges The risks associated with interventional spine procedures are one of the significant challenges restricting the market growth. Patients, especially in developing countries, may be reluctant to undergo spinal interventions due to concerns about possible risks. Some patients may choose not to undergo vertebroplasty because of the risk of cement leakage. In addition, surgery can shrink the vertebrae, increasing the risk of future fractures. Important early consequences of vertebral fractures include laceration and leakage of extra vertebral polymethylmethacrylate (PMMA) cement through the venous system, which can lead to spinal stenosis and pulmonary cement embolism. In addition, systemic allergic reactions, hematomas, or cement toxicity reactions pose significant risks during spinal intervention procedures. Hence, risks associated with interventional spine procedures are expected to restrict market growth during the forecast period. Drivers, Trends & Challenges have an impact on market dynamics and can impact businesses. Find some insights from a sample report! The spinal implants and surgical devices market report provides critical information and factual data, with a qualitative and quantitative study of the market based on market drivers and limitations as well as prospects. Why Buy? Add credibility to the strategy Analyzes competitor's offerings. Get a holistic view of the market Grow your profit margin with Technavio - Buy the Report What are the key data covered in this Spinal Implants and Surgical Devices Market report? CAGR of the market during the forecast period Detailed information on factors that will drive the growth of the spinal implants and surgical devices market between 2023 and 2027 Precise estimation of the size of the spinal implants and surgical devices market and its contribution to the market with a focus on the parent market Accurate predictions about upcoming trends and changes in consumer behavior Growth of the spinal implants and surgical devices market across North America, Europe, Asia, and the Rest of the World (ROW) A thorough analysis of the market's competitive landscape and detailed information about companies Comprehensive analysis of factors that will challenge the growth of spinal implants and surgical devices market companies Gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform Related Reports The elastomeric infusion pumps market is estimated to grow by USD 800.97 million at a CAGR of 7.07% between 2022 and 2027. Furthermore, this report extensively covers market segmentation by application (pain management, antibiotic or antiviral, chemotherapy, and others), end-user (hospitals, ambulatory service centers, clinics, and others), and geography (APAC, North America, Europe, Middle East and Africa, and South America). The high demand for advanced infusion pumps is a major trend in the market. The neuromodulation market is estimated to grow by USD 5,332.29 million at a CAGR of 12.02% between 2022 and 2027. Furthermore, this report extensively covers market segmentation by product (implantable neuromodulation devices and external neuromodulation devices) end-user (hospitals, ASCS, and others), and geography (APAC, North America, Europe, Middle East and Africa, and South America). The expanding applications of neuromodulation therapies is a major trend in the market. Table of Contents 1 Executive Summary 1.1 Market Overview Exhibit 01: Executive Summary – Chart on Market Overview Exhibit 02: Executive Summary – Data Table on Market Overview Exhibit 03: Executive Summary – Chart on Global Market Characteristics Exhibit 04: Executive Summary – Chart on Market by Geography Exhibit 05: Executive Summary – Chart on Market Segmentation by Type Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user Exhibit 07: Executive Summary – Chart on Incremental Growth Exhibit 08: Executive Summary – Data Table on Incremental Growth Exhibit 09: Executive Summary – Chart on Company Market Positioning 2 Market Landscape 2.1 Market ecosystem Exhibit 10: Parent market Exhibit 11: Market Characteristics 3 Market Sizing 3.1 Market definition Exhibit 12: Offerings of companies included in the market definition 3.2 Market segment analysis Exhibit 13: Market segments 3.3 Market size 2022 3.4 Market outlook: Forecast for 2022-2027 Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million) Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million) Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%) Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%) 4 Historic Market Size 4.1 Global spinal implants and surgical devices market 2017 - 2021 Exhibit 18: Historic Market Size – Data Table on global spinal implants and surgical devices market 2017 - 2021 ($ million) 4.2 Type Segment Analysis 2017 - 2021 Exhibit 19: Historic Market Size – Type Segment 2017 - 2021 ($ million) 4.3 End-user Segment Analysis 2017 - 2021 Exhibit 20: Historic Market Size – End-user Segment 2017 - 2021 ($ million) 4.4 Geography Segment Analysis 2017 - 2021 Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million) 4.5 Country Segment Analysis 2017 - 2021 Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million) 5 Five Forces Analysis 5.1 Five forces summary Exhibit 23: Five forces analysis - Comparison between 2022 and 2027 5.2 Bargaining power of buyers Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027 5.3 Bargaining power of suppliers Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027 5.4 Threat of new entrants Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027 5.5 Threat of substitutes Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027 5.6 Threat of rivalry Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027 5.7 Market condition Exhibit 29: Chart on Market condition - Five forces 2022 and 2027 6 Market Segmentation by Type 6.1 Market segments Exhibit 30: Chart on Type - Market share 2022-2027 (%) Exhibit 31: Data Table on Type - Market share 2022-2027 (%) 6.2 Comparison by Type Exhibit 32: Chart on Comparison by Type Exhibit 33: Data Table on Comparison by Type 6.3 Open surgeries - Market size and forecast 2022-2027 Exhibit 34: Chart on Open surgeries - Market size and forecast 2022-2027 ($ million) Exhibit 35: Data Table on Open surgeries - Market size and forecast 2022-2027 ($ million) Exhibit 36: Chart on Open surgeries - Year-over-year growth 2022-2027 (%) Exhibit 37: Data Table on Open surgeries - Year-over-year growth 2022-2027 (%) 6.4 Minimally invasive surgeries - Market size and forecast 2022-2027 Exhibit 38: Chart on Minimally invasive surgeries - Market size and forecast 2022-2027 ($ million) Exhibit 39: Data Table on Minimally invasive surgeries - Market size and forecast 2022-2027 ($ million) Exhibit 40: Chart on Minimally invasive surgeries - Year-over-year growth 2022-2027 (%) Exhibit 41: Data Table on Minimally invasive surgeries - Year-over-year growth 2022-2027 (%) 6.5 Market opportunity by Type Exhibit 42: Market opportunity by Type ($ million) Exhibit 43: Data Table on Market opportunity by Type ($ million) 7 Market Segmentation by End-user 7.1 Market segments Exhibit 44: Chart on End-user - Market share 2022-2027 (%) Exhibit 45: Data Table on End-user - Market share 2022-2027 (%) 7.2 Comparison by End-user Exhibit 46: Chart on Comparison by End-user Exhibit 47: Data Table on Comparison by End-user 7.3 Hospitals - Market size and forecast 2022-2027 Exhibit 48: Chart on Hospitals - Market size and forecast 2022-2027 ($ million) Exhibit 49: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million) Exhibit 50: Chart on Hospitals - Year-over-year growth 2022-2027 (%) Exhibit 51: Data Table on Hospitals - Year-over-year growth 2022-2027 (%) 7.4 Ambulatory surgical centers - Market size and forecast 2022-2027 Exhibit 52: Chart on Ambulatory surgical centers - Market size and forecast 2022-2027 ($ million) Exhibit 53: Data Table on Ambulatory surgical centers - Market size and forecast 2022-2027 ($ million) Exhibit 54: Chart on Ambulatory surgical centers - Year-over-year growth 2022-2027 (%) Exhibit 55: Data Table on Ambulatory surgical centers - Year-over-year growth 2022-2027 (%) 7.5 Specialty clinics - Market size and forecast 2022-2027 Exhibit 56: Chart on Specialty clinics - Market size and forecast 2022-2027 ($ million) Exhibit 57: Data Table on Specialty clinics - Market size and forecast 2022-2027 ($ million) Exhibit 58: Chart on Specialty clinics - Year-over-year growth 2022-2027 (%) Exhibit 59: Data Table on Specialty clinics - Year-over-year growth 2022-2027 (%) 7.6 Market opportunity by End-user Exhibit 60: Market opportunity by End-user ($ million) Exhibit 61: Data Table on Market opportunity by End-user ($ million) 8 Customer Landscape 8.1 Customer landscape overview Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria 9 Geographic Landscape 9.1 Geographic segmentation Exhibit 63: Chart on Market share by geography 2022-2027 (%) Exhibit 64: Data Table on Market share by geography 2022-2027 (%) 9.2 Geographic comparison Exhibit 65: Chart on Geographic comparison Exhibit 66: Data Table on Geographic comparison 9.3 North America - Market size and forecast 2022-2027 Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million) Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million) Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%) Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%) 9.4 Europe - Market size and forecast 2022-2027 Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million) Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million) Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%) Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%) 9.5 Asia - Market size and forecast 2022-2027 Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million) Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million) Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%) Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%) 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) 9.7 US - Market size and forecast 2022-2027 Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million) Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million) Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%) Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%) 9.8 Germany - Market size and forecast 2022-2027 Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million) Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million) Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%) Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%) 9.9 UK - Market size and forecast 2022-2027 Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million) Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million) Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%) Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%) 9.10 Japan - Market size and forecast 2022-2027 Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ million) Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ million) Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%) Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%) 9.11 China - Market size and forecast 2022-2027 Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million) Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million) Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%) Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%) 9.12 Market opportunity by geography Exhibit 103: Market opportunity by geography ($ million) Exhibit 104: Data Tables on Market opportunity by geography ($ million) 10 Drivers, Challenges, and Trends 10.1 Market drivers 10.2 Market challenges 10.3 Impact of drivers and challenges Exhibit 105: Impact of drivers and challenges in 2022 and 2027 10.4 Market trends 11 Company Landscape 11.1 Overview 11.2 Vendor landscape Exhibit 106: Overview on Criticality of inputs and Factors of differentiation 11.3 Landscape disruption Exhibit 107: Overview on factors of disruption 11.4 Industry risks Exhibit 108: Impact of key risks on business 12 Vendor Analysis 12.1 Companies covered Exhibit 109: Companies covered 12.2 Market positioning of Companies Exhibit 110: Matrix on vendor position and classification 12.3 Abbott Laboratories Exhibit 111: Abbott Laboratories - Overview Exhibit 112: Abbott Laboratories - Business segments Exhibit 113: Abbott Laboratories - Key news Exhibit 114: Abbott Laboratories - Key offerings Exhibit 115: Abbott Laboratories - Segment focus 12.4 Alphatec Holdings Inc. Exhibit 116: Alphatec Holdings Inc. - Overview Exhibit 117: Alphatec Holdings Inc. - Product / Service Exhibit 118: Alphatec Holdings Inc. - Key offerings 12.5 B. Braun Melsungen AG Exhibit 119: B. Braun Melsungen AG - Overview Exhibit 120: B. Braun Melsungen AG - Business segments Exhibit 121: B. Braun Melsungen AG - Key news Exhibit 122: B. Braun Melsungen AG - Key offerings Exhibit 123: B. Braun Melsungen AG - Segment focus 12.6 Bioventus LLC Exhibit 124: Bioventus LLC - Overview Exhibit 125: Bioventus LLC - Business segments Exhibit 126: Bioventus LLC - Key news Exhibit 127: Bioventus LLC - Key offerings Exhibit 128: Bioventus LLC - Segment focus 12.7 Boston Scientific Corp. Exhibit 129: Boston Scientific Corp. - Overview Exhibit 130: Boston Scientific Corp. - Business segments Exhibit 131: Boston Scientific Corp. - Key news Exhibit 132: Boston Scientific Corp. - Key offerings Exhibit 133: Boston Scientific Corp. - Segment focus 12.8 Globus Medical Inc. Exhibit 134: Globus Medical Inc. - Overview Exhibit 135: Globus Medical Inc. - Product / Service Exhibit 136: Globus Medical Inc. - Key offerings 12.9 Integra Lifesciences Holdings Corp. Exhibit 137: Integra Lifesciences Holdings Corp. - Overview Exhibit 138: Integra Lifesciences Holdings Corp. - Business segments Exhibit 139: Integra Lifesciences Holdings Corp. - Key news Exhibit 140: Integra Lifesciences Holdings Corp. - Key offerings Exhibit 141: Integra Lifesciences Holdings Corp. - Segment focus 12.10 Johnson and Johnson Services Inc. Exhibit 142: Johnson and Johnson Services Inc. - Overview Exhibit 143: Johnson and Johnson Services Inc. - Business segments Exhibit 144: Johnson and Johnson Services Inc. - Key news Exhibit 145: Johnson and Johnson Services Inc. - Key offerings Exhibit 146: Johnson and Johnson Services Inc. - Segment focus 12.11 Medtronic Plc Exhibit 147: Medtronic Plc - Overview Exhibit 148: Medtronic Plc - Business segments Exhibit 149: Medtronic Plc - Key news Exhibit 150: Medtronic Plc - Key offerings Exhibit 151: Medtronic Plc - Segment focus 12.12 Nuvasive Inc. Exhibit 152: Nuvasive Inc. - Overview Exhibit 153: Nuvasive Inc. - Business segments Exhibit 154: Nuvasive Inc. - Key news Exhibit 155: Nuvasive Inc. - Key offerings Exhibit 156: Nuvasive Inc. - Segment focus 12.13 Orthofix Medical Inc. Exhibit 157: Orthofix Medical Inc. - Overview Exhibit 158: Orthofix Medical Inc. - Business segments Exhibit 159: Orthofix Medical Inc. - Key offerings Exhibit 160: Orthofix Medical Inc. - Segment focus 12.14 RTI Surgical Inc. Exhibit 161: RTI Surgical Inc. - Overview Exhibit 162: RTI Surgical Inc. - Product / Service Exhibit 163: RTI Surgical Inc. - Key offerings 12.15 Spineart SA Exhibit 164: Spineart SA - Overview Exhibit 165: Spineart SA - Product / Service Exhibit 166: Spineart SA - Key offerings 12.16 Stryker Corp. Exhibit 167: Stryker Corp. - Overview Exhibit 168: Stryker Corp. - Business segments Exhibit 169: Stryker Corp. - Key news Exhibit 170: Stryker Corp. - Key offerings Exhibit 171: Stryker Corp. - Segment focus 12.17 ulrich GmbH and Co. KG Exhibit 172: ulrich GmbH and Co. KG - Overview Exhibit 173: ulrich GmbH and Co. KG - Product / Service Exhibit 174: ulrich GmbH and Co. KG - Key offerings 13 Appendix 13.1 Scope of the report 13.2 Inclusions and exclusions checklist Exhibit 175: Inclusions checklist Exhibit 176: Exclusions checklist 13.3 Currency conversion rates for US$ Exhibit 177: Currency conversion rates for US$ 13.4 Research methodology Exhibit 178: Research methodology Exhibit 179: Validation techniques employed for market sizing Exhibit 180: Information sources 13.5 List of abbreviations Exhibit 181: List of abbreviations About Us Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contact Technavio Research Jesse Maida Media & Marketing Executive US: +1 844 364 1100 UK: +44 203 893 3200 Email: [email protected] Website: SOURCE Technavio

SHELTON, CT--(MARKET WIRE)--Apr 16, 2007 -- Spine Wave, Inc., a company that develops and markets innovative spinal surgical solutions, announced it has received FDA 510(k) clearance to market its StaXx® FX Structural Kyphoplasty System for the treatment of vertebral compression fractures. The StaXx® FX System features innovative PEEK wafers which are stacked in situ to simultaneously distract and support the fractured vertebral body. The minimally invasive system is designed to provide pain relief and a controlled vertical fracture reduction. Mark LoGuidice, Chairman and Chief Executive Officer of Spine Wave, commented: "The FDA's clearance of the StaXx® FX System is a key milestone for Spine Wave. This allows us to enter a large, rapidly growing market with a very promising and highly differentiated technology. As one of three major products we will bring to the U.S. market in 2007, the StaXx® FX System will play a pivotal role in helping us to attract and build a world-class direct U.S. sales organization." "I have been working closely with the Spine Wave engineers on the development of this technology for several years," stated Harvinder Sandhu, M.D., of the Hospital for Special Surgery in New York. "The system has performed well in extensive laboratory tests. In addition, the European clinical results have been very encouraging. I believe the StaXx® FX System will prove to be a tool which will allow physicians to provide immediate pain relief and meaningful sagittal correction when treating patients with vertebral compression fractures." Spine Wave will begin a controlled release of the StaXx® FX System during the second quarter of 2007. Physician training will be the focus throughout the remainder of 2007 with a market launch expected later in the year. About Spine Wave, Inc. Spine Wave, headquartered in Shelton, Connecticut, is focused on the development of clinical solutions for three of the largest and fastest growing spinal market segments: nuclear replacement and augmentation, vertebral compression fracture repair and spinal fusion. The Company's product portfolio includes the NuCore™ Injectable Nucleus, the StaXx® FX Structural Kyphoplasty System, the StaXx® XD Expandable Device, the CapSure(TM) PS Spine System and several additional products in development. For further information, visit the Company's website at Contact: Contact: Carmen L. Diersen Chief Financial Officer (203) 944-9494, extension 111 CDiersen@SpineWave.com Source: Spine Wave >>> Discuss This Story